SLC22A12 Antibodies

Santa Cruz Biotechnology offers a broad range of SLC22A12 monoclonal antibodies for research focused on understanding this important protein. The monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). SLC22A12, also known as URAT1, is a crucial transporter protein involved in the renal reabsorption of urate, playing a significant role in maintaining uric acid homeostasis in the body. Dysregulation of SLC22A12 can lead to conditions such as gout and kidney disease, making it a vital target for research in metabolic disorders. Understanding the function and regulation of SLC22A12 is essential for developing therapeutic strategies for these diseases. Researchers can utilize SLC22A12 monoclonal antibodies to investigate protein expression patterns in various tissue types. Advanced detection methods, including horseradish peroxidase (HRP), phycoerythrin (PE), and fluorescein isothiocyanate (FITC) conjugates, enable precise visualization of SLC22A12 localization and expression. The high specificity of SLC22A12 monoclonal antibodies allows for reliable and reproducible results across multiple experimental platforms. Santa Cruz Biotechnology monoclonal antibodies for SLC22A12 research support scientists worldwide in advancing our understanding of metabolic diseases and potential therapeutic interventions.